Shoji Fumihiro, Yamazaki Koji, Kouso Hidenori, Mori Ryo, Takeo Sadanori
Department of Thoracic Surgery, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
Department of Thoracic Surgery, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
Ann Thorac Surg. 2016 May;101(5):1903-8. doi: 10.1016/j.athoracsur.2015.11.066. Epub 2016 Feb 22.
Although stage IA non-small cell lung cancer has an optimistic survival rate, up to 10% of these patients relapse after surgical procedures and die. We retrospectively analyzed clinicopathologic features of patients with stage IA non-small cell lung cancer to identify recurrence predictors and to investigate effects of preoperative serum Krebs von den Lungen-6 (PS-KL-6) concentrations.
We selected 204 consecutive patients with stage IA non-small cell lung cancer treated from December 2003 to December 2009 for this study and tested their PS-KL-6 concentrations in univariate and multivariate Cox regression analyses of recurrence-free survival (RFS).
High PS-KL-6 concentration (PS-KL6(High)) was significantly associated with sex (p = 0.0006), smoking status (p = 0.0438), histology (p = 0.0049), and postoperative recurrence (p = 0.0058). Both intratumoral blood vessel invasion (p = 0.0345) and PS-KL6(High) (p = 0.0021) were identified as independent predictors of shorter RFS. Relative risk of patients with PS-KL6(High) was 3.478 compared with patients with low PS-KL-6 concentration (PS-KL6(Low); 95% confidence interval: 1.576 to 8.013). Among patients with tumors larger than 2 cm (T1b), the PS-KL6(High) group had significantly shorter RFS than the PS-KL6(Low) group (p = 0.0040).
PS-KL-6 concentration is a simple and novel predictor of recurrence in patients with stage IA non-small cell lung cancer and might help to identify patients who will need more careful follow-up among T1bN0M0 series.
尽管IA期非小细胞肺癌患者的生存率较为乐观,但仍有高达10%的患者在手术后复发并死亡。我们回顾性分析了IA期非小细胞肺癌患者的临床病理特征,以确定复发预测因素,并研究术前血清克雷伯斯-冯-登-伦根-6(PS-KL-6)浓度的影响。
我们选择了2003年12月至2009年12月期间连续治疗的204例IA期非小细胞肺癌患者进行本研究,并在无复发生存期(RFS)的单因素和多因素Cox回归分析中检测了他们的PS-KL-6浓度。
高PS-KL-6浓度(PS-KL6(High))与性别(p = 0.0006)、吸烟状况(p = 0.0438)、组织学(p = 0.0049)和术后复发(p = 0.0058)显著相关。肿瘤内血管侵犯(p = 0.0345)和PS-KL6(High)(p = 0.0021)均被确定为RFS较短的独立预测因素。与低PS-KL-6浓度(PS-KL6(Low))的患者相比,PS-KL6(High)患者的相对风险为3.478(95%置信区间:1.576至8.013)。在肿瘤大于***2厘米(T1b)的患者中,PS-KL6(High)组的RFS明显短于PS-KL6(Low)组(p = 0.0040)。
PS-KL-6浓度是IA期非小细胞肺癌患者复发的一个简单而新颖的预测因素,可能有助于在T1bN0M0系列中识别需要更密切随访的患者。